Clinics I work with
My reviews
4.9
My family and I were very impressed with Dr. Ko. He managed to demonstrate his expertise while projecting a very caring attitude at the same time.
Selected research
-
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study.
The Lancet. Oncology
-
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.
JAMA oncology
-
Variability in multimodality treatment influences survival in non-metastatic gastric cancer patients.
Journal of gastrointestinal oncology
Clinical trials
A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer
Overall survival (OS) is defined from the time of initiation of treatment until death due to any cause. Subjects still alive at the time of an analysis will be considered censored at their date of last contact.
Recruiting
APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction ...
Adverse events will be summarized by presenting, at each dose level, the number and percentage of patients having any adverse event, having an adverse event in each body system and having each individual adverse event. If no patie...
Recruiting